US Edition3 Articles
3 Articles
DEXYPTAGE - The U.S. drug agency has just authorised Journavx. Its active substance, susetrigin, targets a brand new mechanism of pain and does not a priori lead to any risk of addiction.
·Paris, France
Read Full Article
Authorities in the United States have approved suzetrigine, a painkiller that does not cause addiction, providing a safe alternative to traditional opioids. The drug, available only with a prescription, works by blocking pain signals before they reach the brain. Suzetrigine comes in a context marked by the opioid crisis, which has led to thousands of deaths from opioid and fentanyl overdoses. Health authorities in the United States recently appr…
Coverage Details
Total News Sources3
Leaning Left1Leaning Right1Center0Last UpdatedBias Distribution50% Left, 50% Right
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
50% Right
L 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
